Abstract:OBJECTIVE:To observe the serial changes of plasma microparticle procoagulant activity in patients with traumatic brain injury (TBI) and evaluate its correlations with outcome and pathophysiology of TBI.METHODS:A total of 139 consecutive patients with isolated moderate or severe head trauma and 40 age- and sex-matched healthy controls were enrolled. Plasma samples were obtained on entry in healthy controls, as well as on admission and at day 1, day 2, day 3, day 5, and day 7 after TBI in the patients. Its concentration was measured by a prothrombinase assay.RESULTS:Fifty patients (36.0%) died from TBI in a month. After TBI, plasma microparticle procoagulant activity in the patients increased during the 6-hour period immediately, peaked in 24 hours and decreased gradually thereafter. It was substantially higher than that of healthy controls during the 7-day period using analysis of covariate (P < 0.01). A multivariate analysis selected plasma microparticle procoagulant activity (OR 1.432, 95% CI 1.194-1.719, P < 0. 01) as an independent predictor for 1-month mortality. Plasma microparticle procoagulant activities of non-survivals were statistically significantly higher than those of survivals (P = 0.01), and plasma microparticle procoagulant activities of patients with severe TBI were obviously higher than those of patients with moderate TBI (P = 0.002) using repeated-measures analysis. Plasma microparticle procoagulant activities of patients were negatively associated with Glasgow coma scale scores using Spearman correlation coefficient (P < 0.05). A multivariate linear regression selected plasma D-dimer level (P = 0.012) and plasma C-creative protein level (P = 0.019) related to plasma microparticle procoagulant activities. A receiver operating characteristic curve identified the cutoff levels of plasma microparticle procoagulant activities (12.2 U/ml) predicting 1-month mortality of patients with the high sensitivity (72.0%) and specificity values (85.4%). Areas under curve (AUC) of plasma resistin level (AUC = 0.847 +/- 0.037) was smaller than those of GCS scores (AUC = 0.917 +/- 0.023), but this difference failed to reach statistical significance (P = 0.104).CONCLUSION:Increased activity of plasma microparticle procoagulant is found after traumatic brain injury. It may contribute to inflammatory reaction and coagulation cascade and is associated with a poor clinical outcome.

The content determination of gonadotropin-releasing hormone in cerebrospinal fluid patients with traumatic brain injury

Peripheral Inflammatory Markers in Patients with Prolonged Disorder of Consciousness after Severe Traumatic Brain Injury.

Clinical Analysis of Gonadotropin-Releasing Hormone in Cerebrospinal Fluid after Hypertensive Cerebral Hemorrhage

Early Changes of Endothelin, Nitric Oxide and Arginine-Vasopressin in Patients with Acute Cerebral Injury.

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Dynamically Monitoring Tissue Factor and Tissue Factor Pathway Inhibitor Following Secondary Brain Injury

Changes of hypothalamus corticotropin releasing factor levels in children with acute brain injury

Changes of Arginine Vasopressin in Elderly Patients with Acute Traumatic Cerebral Injury

Inhibitory Effect of Progesterone on Inflammatory Factors after Experimental Traumatic Brain Injury.

Change in Plasma Microparticle Procoagulant Activity after Traumatic Brain Injury

Brain-derived Neurotrophic Factor Combined with Neural Stem Cells Transplantation in Treatment of Severe Traumatic Brain Injury in Rats

The Association of Cell Apoptosis with Cerebral Edema and Intracranial Pressure after Traumatic Craniocerebral Injury

Clinical significance of matrix metalloproteinases-9 content in cerebrospinal fluid of brain injury

BNP and NT-proBNP Concentrations in Paired cerebrospinal Fluid and Plasma Samples of Patients with Traumatic Brain Injury

Clinical Study on the Changes of Plasma Hcy, β2 -m, Cortisol, NPY Levels and NPY Contents in CSF in Patients with Acute Traumatic Intracranial Hemorrhage as well as Patients with Cerebral Infarction

Changes of Hypothalamus Corticotrophin Releasing Factor Levels in Ill Children with Acute Brain Injury

Dynamic Changes of Serum Glial Fibrillary Acidic Protein Content in Patients with Brain Injury and Their Cllnical Significance

Dynamic Changes and Effects of H2S, IGF-1, and GH in the Traumatic Brain Injury

The Change and Clinical Significance of Serum Aquaporin-4 and Pnf-H in Patients with Moderate and Severe Traumatic Brain Injury

Study on the Relationship between Spontaneous Cerebral Hemorrhage and Serum B-type Brain Natriuretic Peptide

The Significance of the Detection of Serum Lactate Dehydrogenase, Hypersensitive C-Reactive Protein, and N-Terminal Pro-Brain Natriuretic Peptide for the Evaluation of the Severity and Progression of Pediatric Patients with Traumatic Brain Injury